Completed NA INTERVENTIONAL 6-arm NCT00504309

Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides (OMEGA)

Omacor: Measures of Endothelial Function and triGlyceride Alteration

Sponsor: Penn State University

Interventions 4/day of 1g P-OM3 capsules 4/day of 4g P-OM3 capsules Corn Oil Placebo, 4 capsules/day for 8 weeks

Updated 7 times since 2017 Last updated: Feb 13, 2018 Started: Jul 31, 2007 Primary completion: Jan 31, 2009 Completion: Jan 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Hypertriglyceridemia and is currently completed. Penn State University leads this study, which shows 7 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Mar 2018 — Jun 2018 [monthly]

Completed NA

▶ Show 2 earlier versions

Feb 2017 — Mar 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Penn State University
Reliant Pharmaceuticals

Data source: Penn State University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• University Park, United States